Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

The surge in Biocon share price came after the company announced that United States Food and Drug Administration (USFDA) has ...

Stock market today: The Nifty 50 index has a support at 23,400 mark, and the 50-stock index faces a resistance at 23,700 ...

Biocon is a prominent global biopharmaceutical company driven by innovation, specialising in therapies for chronic conditions ...

With the Bengaluru unit's clearance from the USFDA out of the window, investors are now eagerly waiting for regulatory ...

Mayuresh Joshi, Head Equity, Marketsmith India, shared his insights on the performance of various companies. He noted that ...

Shares of Biocon gained over 8 per cent after the US Food and Drug Administration (USFDA) classified its Bengaluru unit as ...

Biocon Ltd shares jumped 8.4% on Monday after receiving a ‘Voluntary Action Indicated’ status from the USFDA for its ...

The brokerage maintains its Neutral stance on the stock, as the current valuation captures the earnings upside.

The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...

Biocon Limited's quarterly earnings report, debt reduction strategy, R&D investment, and CapEx plans for future growth ...

I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...